Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Sanofi partner Merrimack Pharmaceuticals raises $77M
Bizjournals.com
Thursday, April 14, 2011 - 11:49am
tags:
Merrimack Pharmaceuticals, Sanofi, cancer, series G
The Supreme Court & How To Delay Generics
Pharmalot
Thursday, April 14, 2011 - 11:16am
tags:
generics, Supreme Court, Novo Nordisk, Prandin, Caraco
Forest Laboratories says CEO to challenge move by HHS to exclude him from health care programs
Yahoo/AP
Thursday, April 14, 2011 - 11:13am
tags:
HHS, Forest Labs, Pharma CEOs, Howard Solomon, Clinical Data
Sanofi-Aventis Said to Seek Buyer in Bidding for U.S. Dermatology Unit
Bloomberg
Thursday, April 14, 2011 - 11:10am
tags:
M&A, dermatology, Sanofi
Vertex Receives Good News on Hepatitis C Treatment
Seeking Alpha
Thursday, April 14, 2011 - 11:01am
tags:
Vertex Pharmaceuticals, hepatitis C, Telaprevir, Merck, bacepravir, Victrella
4 Biotech Penny Stocks to Buy: Navellier
TheStreet.com
Thursday, April 14, 2011 - 10:59am
tags:
Zalicus, YM BioSciences, Dynavax, Aeterna Zentaris
Johnson & Johnson recalls Topamax for odor
CNN Money
Thursday, April 14, 2011 - 10:57am
tags:
JNJ, recalls, Topamax
Roche quarterly sales drop amid healthcare curbs
Marketwatch
Thursday, April 14, 2011 - 10:56am
tags:
Roche, earnings
The Death Of The Blockbuster Drug: A Cheat Sheet
Forbes
Thursday, April 14, 2011 - 7:31am
tags:
generics, patents
Abbott’s Potential Billion-Dollar Problem
Motley Fool
Thursday, April 14, 2011 - 7:29am
tags:
Abbott Laboratories, Humira, rheumatoid arthritis
A Decade In Drug Industry Layoffs
Forbes
Wednesday, April 13, 2011 - 5:21pm
tags:
layoffs
Overblown Patent Cliff Concerns Mean You Should Buy Pharma Now
Forbes
Wednesday, April 13, 2011 - 5:19pm
tags:
patents
Aoxing Pharma: An Exercise in Patience
Seeking Alpha
Wednesday, April 13, 2011 - 12:44pm
tags:
Aoxing, China
Analyst ratings boost drug stocks
Marketwatch
Wednesday, April 13, 2011 - 11:08am
tags:
biotech, analysts, Regeneron, GTx, BioSante
Delcath's Disappointing Delay
Motley Fool
Wednesday, April 13, 2011 - 10:56am
tags:
Delcath, chemotherapy
Pfizer, FoldRx drug extends survival
Fierce Biotech
Wednesday, April 13, 2011 - 10:52am
tags:
Pfizer, FoldRx, tafamidis, TTR-FAP
FDA to review potential low testosterone treatment developed by BioSante, licensed to Teva
Yahoo/AP
Wednesday, April 13, 2011 - 10:50am
tags:
BioSante, FDA, testosterone, Teva Pharmaceuticals, Bio-T-Gel
Big Pharma M&A strategy has failed miserably
Pharma Times, UK
Wednesday, April 13, 2011 - 9:18am
tags:
Big Pharma, M&A
Biotech Earnings Season Preview
Seeking Alpha
Wednesday, April 13, 2011 - 9:16am
tags:
biotech, earnings, Amgen, Biogen Idec, Gilead Sciences, Alexion
Sun Pharma Research Outshines Parent
WSJ Online
Wednesday, April 13, 2011 - 9:15am
tags:
Sun Pharma, India

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.